{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:21Z","timestamp":1792623981932,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41589-025-01921-4","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:03:47Z","timestamp":1749531827000},"page":"482-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unraveling Alzheimer\u2019s complexity with a distinct A\u03b242 fibril type and specific AV-45 binding"],"prefix":"10.1038","volume":"22","author":[{"given":"Qinyue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-8134","authenticated-orcid":false,"given":"Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-1268","authenticated-orcid":false,"given":"Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1346-6961","authenticated-orcid":false,"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4906-8746","authenticated-orcid":false,"given":"Wenying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-6672","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-1539","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"1921_CR1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert, M. & Spillantini, M. G. A century of Alzheimer\u2019s disease. Science 314, 777\u2013781 (2006).","journal-title":"Science"},{"key":"1921_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"1921_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1921_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"1921_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1921_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"1921_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"1921_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"1921_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1192\/bjp.115.520.267","volume":"115","author":"C McDonald","year":"1969","unstructured":"McDonald, C. Clinical heterogeneity in senile dementia. Br. J. Psychiatry 115, 267\u2013271 (1969).","journal-title":"Br. J. Psychiatry"},{"key":"1921_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/jcbfm.1985.25","volume":"5","author":"JV Haxby","year":"1985","unstructured":"Haxby, J. V., Duara, R., Grady, C. L., Cutler, N. R. & Rapoport, S. I. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer\u2019s disease. J. Cereb. Blood Flow. Metab. 5, 193\u2013200 (1985).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1921_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.36.7.879","volume":"36","author":"R Duara","year":"1986","unstructured":"Duara, R. et al. Positron emission tomography in Alzheimer\u2019s disease. Neurology 36, 879\u2013887 (1986).","journal-title":"Neurology"},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel, J. W. et al. Four distinct trajectories of Tau deposition identified in Alzheimer\u2019s disease. Nat. Med. 27, 871\u2013881 (2021).","journal-title":"Nat. Med."},{"key":"1921_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41586-024-07680-x","volume":"631","author":"MAG Gilbert","year":"2024","unstructured":"Gilbert, M. A. G. et al. CryoET of \u03b2-amyloid and Tau within postmortem Alzheimer\u2019s disease brain. Nature 631, 913\u2013919 (2024).","journal-title":"Nature"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science 375, 167\u2013172 (2022).","journal-title":"Science"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-022-02533-1","volume":"145","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Cryo-EM structures of amyloid-\u03b2 filaments with the Arctic mutation (E22G) from human and mouse brains. Acta Neuropathol. 145, 325\u2013333 (2023).","journal-title":"Acta Neuropathol."},{"key":"1921_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41594-024-01252-3","volume":"31","author":"A Fernandez","year":"2024","unstructured":"Fernandez, A. et al. Cryo-EM structures of amyloid-\u03b2 and Tau filaments in Down syndrome. Nat. Struct. Mol. Biol. 31, 903\u2013909 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1921_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","volume":"154","author":"JX Lu","year":"2013","unstructured":"Lu, J. X. et al. Molecular structure of \u03b2-amyloid fibrils in Alzheimer\u2019s disease brain tissue. Cell 154, 1257\u20131268 (2013).","journal-title":"Cell"},{"key":"1921_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang, W., Yau, W. M., Lu, J. X., Collinge, J. & Tycko, R. Structural variation in amyloid-beta fibrils from Alzheimer\u2019s disease clinical subtypes. Nature 541, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"1921_CR19","doi-asserted-by":"publisher","first-page":"e2023089118","DOI":"10.1073\/pnas.2023089118","volume":"118","author":"U Ghosh","year":"2021","unstructured":"Ghosh, U., Thurber, K. R., Yau, W. M. & Tycko, R. Molecular structure of a prevalent amyloid-beta fibril polymorph from Alzheimer\u2019s disease brain tissue. Proc. Natl Acad. Sci. USA 118, e2023089118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1921_CR20","doi-asserted-by":"publisher","first-page":"e2218831120","DOI":"10.1073\/pnas.2218831120","volume":"120","author":"M Lee","year":"2023","unstructured":"Lee, M., Yau, W. M., Louis, J. M. & Tycko, R. Structures of brain-derived 42-residue amyloid-\u03b2 fibril polymorphs with unusual molecular conformations and intermolecular interactions. Proc. Natl Acad. Sci. USA 120, e2218831120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1921_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of Tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"1921_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature 610, 791\u2013795 (2022).","journal-title":"Nature"},{"key":"1921_CR23","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","volume":"187","author":"RE Bennett","year":"2017","unstructured":"Bennett, R. E. et al. Enhanced Tau aggregation in the presence of amyloid \u03b2. Am. J. Pathol. 187, 1601\u20131612 (2017).","journal-title":"Am. J. Pathol."},{"key":"1921_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon, A. et al. Propagation of Tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73, 685\u2013697 (2012).","journal-title":"Neuron"},{"key":"1921_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168025","volume":"435","author":"Y Shi","year":"2023","unstructured":"Shi, Y., Ghetti, B., Goedert, M. & Scheres, S. H. W. Cryo-EM structures of chronic traumatic encephalopathy Tau filaments with PET ligand flortaucipir. J. Mol. Biol. 435, 168025 (2023).","journal-title":"J. Mol. Biol."},{"key":"1921_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark, C. M. et al. Use of florbetapir-PET for imaging \u03b2-amyloid pathology. JAMA 305, 275\u2013283 (2011).","journal-title":"JAMA"},{"key":"1921_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310\u2013314 (2022).","journal-title":"Nature"},{"key":"1921_CR28","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185, 1346\u20131355(2022).","journal-title":"Cell"},{"key":"1921_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang, Y. X. et al. Amyloid fibrils in disease FTLD-TDP are composed of TMEM106B not TDP-43. Nature 605, 304\u2013309 (2022).","journal-title":"Nature"},{"key":"1921_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-022-00665-3","volume":"32","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. Generic amyloid fibrillation of TMEM106B in patient with Parkinson\u2019s disease dementia and normal elders. Cell Res. 32, 585\u2013588 (2022).","journal-title":"Cell Res."},{"key":"1921_CR31","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1093\/brain\/awad133","volume":"146","author":"CT Vicente","year":"2023","unstructured":"Vicente, C. T. et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain 146, 4055\u20134064 (2023).","journal-title":"Brain"},{"key":"1921_CR32","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.neuron.2023.04.007","volume":"111","author":"AM Stern","year":"2023","unstructured":"Stern, A. M. et al. Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron 111, 2012\u20132020 (2023).","journal-title":"Neuron"},{"key":"1921_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21126-2","volume":"12","author":"L Radamaker","year":"2021","unstructured":"Radamaker, L. et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat. Commun. 12, 875 (2021).","journal-title":"Nat. Commun."},{"key":"1921_CR34","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41589-023-01370-x","volume":"19","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Structural mechanism for specific binding of chemical compounds to amyloid fibrils. Nat. Chem. Biol. 19, 1235\u20131245 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1921_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/BF00689591","volume":"76","author":"H Yamaguchi","year":"1988","unstructured":"Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M. & Ihara, Y. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by \u03b2 protein immunostaining. Acta Neuropathol. 76, 541\u2013549 (1988).","journal-title":"Acta Neuropathol."},{"key":"1921_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41583-022-00603-7","volume":"23","author":"D Li","year":"2022","unstructured":"Li, D. & Liu, C. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Nat. Rev. Neurosci. 23, 523\u2013534 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"1921_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"1921_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41589-020-00708-z","volume":"17","author":"D Li","year":"2021","unstructured":"Li, D. & Liu, C. Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease. Nat. Chem. Biol. 17, 237\u2013245 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"1921_CR39","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1073\/pnas.1922741117","volume":"117","author":"K Zhao","year":"2020","unstructured":"Zhao, K. et al. Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM. Proc. Natl Acad. Sci. USA 117, 20305\u201320315 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1921_CR40","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41593-023-01484-4","volume":"26","author":"M Zielinski","year":"2023","unstructured":"Zielinski, M. et al. Cryo-EM of A\u03b2 fibrils from mouse models find tg-APP(ArcSwe) fibrils resemble those found in patients with sporadic Alzheimer\u2019s disease. Nat. Neurosci. 26, 2073\u20132080 (2023).","journal-title":"Nat. Neurosci."},{"key":"1921_CR41","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2018.1346","volume":"75","author":"A de Wilde","year":"2018","unstructured":"de Wilde, A. et al. Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: yhe ABIDE project. JAMA Neurol. 75, 1062\u20131070 (2018).","journal-title":"JAMA Neurol."},{"key":"1921_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1921_CR43","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","volume":"68","author":"DA Wolk","year":"2011","unstructured":"Wolk, D. A. et al. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch. Neurol. 68, 1398\u20131403 (2011).","journal-title":"Arch. Neurol."},{"key":"1921_CR44","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and Tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"1921_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-018-0424-5","volume":"10","author":"S Salloway","year":"2018","unstructured":"Salloway, S. et al. Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-\u03b2 antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer\u2019s disease (BLAZE). Alzheimers Res. Ther. 10, 96 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"1921_CR46","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson, K. A. et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 9, S72\u2013S83 (2013).","journal-title":"Alzheimers Dement."},{"key":"1921_CR47","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri, O. et al. Florbetaben PET imaging to detect amyloid \u03b2 plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement. 11, 964\u2013974 (2015).","journal-title":"Alzheimers Dement."},{"key":"1921_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel, H. et al. Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 10, 424\u2013435 (2011).","journal-title":"Lancet Neurol."},{"key":"1921_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"C Curtis","year":"2015","unstructured":"Curtis, C. et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol. 72, 287\u2013294 (2015).","journal-title":"JAMA Neurol."},{"key":"1921_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe, R. et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann. Neurol. 68, 319\u2013329 (2010).","journal-title":"Ann. Neurol."},{"key":"1921_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jalz.2012.01.006","volume":"9","author":"R Duara","year":"2013","unstructured":"Duara, R. et al. Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 9, 295\u2013301 (2013).","journal-title":"Alzheimers Dement."},{"key":"1921_CR52","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","volume":"186","author":"J Xiang","year":"2023","unstructured":"Xiang, J. et al. Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell 186, 3350\u20133367 (2023).","journal-title":"Cell"},{"key":"1921_CR53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","volume":"141","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Cryo-EM structures of Tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697\u2013708 (2021).","journal-title":"Acta Neuropathol."},{"key":"1921_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38537-y","volume":"14","author":"GE Merz","year":"2023","unstructured":"Merz, G. E. et al. Stacked binding of a PET ligand to Alzheimer\u2019s Tau paired helical filaments. Nat. Commun. 14, 3048 (2023).","journal-title":"Nat. Commun."},{"key":"1921_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41594-020-0399-3","volume":"27","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat. Struct. Mol. Biol. 27, 363\u2013372 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1921_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41421-024-00674-z","volume":"10","author":"Q Zhao","year":"2024","unstructured":"Zhao, Q. et al. A Tau PET tracer PBB3 binds to TMEM106B amyloid fibril in brain. Cell Discov. 10, 50 (2024).","journal-title":"Cell Discov."},{"key":"1921_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s40478-023-01694-8","volume":"11","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Cryo-EM structures of A\u03b240 filaments from the leptomeninges of individuals with Alzheimer\u2019s disease and cerebral amyloid angiopathy. Acta Neuropathol. Commun. 11, 191 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"1921_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"1921_CR59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"1921_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsb.2017.02.003","volume":"198","author":"S He","year":"2017","unstructured":"He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163\u2013176 (2017).","journal-title":"J. Struct. Biol."},{"key":"1921_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1039\/D2FD00034B","volume":"240","author":"S Lovestam","year":"2022","unstructured":"Lovestam, S. & Scheres, S. H. W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 240, 243\u2013260 (2022).","journal-title":"Faraday Discuss."},{"key":"1921_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1107\/S2059798319016577","volume":"76","author":"SHW Scheres","year":"2020","unstructured":"Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D Struct. Biol. 76, 94\u2013101 (2020).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"1921_CR63","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41592-024-02304-8","volume":"21","author":"D Kimanius","year":"2024","unstructured":"Kimanius, D. et al. Data-driven regularization lowers the size barrier of cryo-EM structure determination. Nat. Methods 21, 1216\u20131221 (2024).","journal-title":"Nat. Methods"},{"key":"1921_CR64","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"1921_CR65","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"1921_CR66","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1921_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01921-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:01:16Z","timestamp":1772424076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01921-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1038\/s41589-025-01921-4","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"17 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}